B2B CHANGE’s new six-year phase and $38.4 million grant renewal from the National Heart, Lung, and Blood Institute were recently featured in a national PR Newswire announcement. The renewed funding will build on more than 15 years of congenital heart disease genetic research while expanding the program’s focus to long-term follow-up and understanding how genetic differences influence health outcomes across the lifespan. Read the full announcement on PR Newswire.
Image
Image
B2B CHANGE Grant Renewal Featured on PR Newswire
Date
October 29, 2026